1. Home
  2. NVCR vs VSAT Comparison

NVCR vs VSAT Comparison

Compare NVCR & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • VSAT
  • Stock Information
  • Founded
  • NVCR 2000
  • VSAT 1986
  • Country
  • NVCR Jersey
  • VSAT United States
  • Employees
  • NVCR N/A
  • VSAT N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • NVCR Health Care
  • VSAT Technology
  • Exchange
  • NVCR Nasdaq
  • VSAT Nasdaq
  • Market Cap
  • NVCR 1.8B
  • VSAT 2.4B
  • IPO Year
  • NVCR 2015
  • VSAT 1996
  • Fundamental
  • Price
  • NVCR $17.49
  • VSAT $10.38
  • Analyst Decision
  • NVCR Buy
  • VSAT Buy
  • Analyst Count
  • NVCR 5
  • VSAT 7
  • Target Price
  • NVCR $26.60
  • VSAT $21.14
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • VSAT 1.8M
  • Earning Date
  • NVCR 10-30-2024
  • VSAT 11-06-2024
  • Dividend Yield
  • NVCR N/A
  • VSAT N/A
  • EPS Growth
  • NVCR N/A
  • VSAT N/A
  • EPS
  • NVCR N/A
  • VSAT N/A
  • Revenue
  • NVCR $549,964,000.00
  • VSAT $4,630,427,000.00
  • Revenue This Year
  • NVCR $16.23
  • VSAT $8.43
  • Revenue Next Year
  • NVCR $6.09
  • VSAT $3.27
  • P/E Ratio
  • NVCR N/A
  • VSAT N/A
  • Revenue Growth
  • NVCR 8.33
  • VSAT 67.71
  • 52 Week Low
  • NVCR $10.87
  • VSAT $9.98
  • 52 Week High
  • NVCR $24.74
  • VSAT $29.11
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • VSAT 36.14
  • Support Level
  • NVCR $15.61
  • VSAT $10.10
  • Resistance Level
  • NVCR $17.31
  • VSAT $10.65
  • Average True Range (ATR)
  • NVCR 1.29
  • VSAT 0.49
  • MACD
  • NVCR 0.05
  • VSAT 0.10
  • Stochastic Oscillator
  • NVCR 11.59
  • VSAT 23.60

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: satellite services: which provides satellite-based high-speed broadband services to consumers, enterprises, and commercial airlines; commercial networks: which develops end-to-end communication and connectivity systems; and government systems: which produces network-centric Internet Protocol-based secure government communication systems. A large majority of the firm's revenue is generated in the United States, it also has its presence in non U.S. countries.

Share on Social Networks: